CME Group Inc. (NASDAQ:CME)‘s stock had its “hold” rating reaffirmed by investment analysts at Keefe, Bruyette & Woods in a research report issued on Friday. They presently have a $127.00 target price on the financial services provider’s stock. Keefe, Bruyette & Woods’ price target would suggest a potential upside of 1.31% from the stock’s previous close.
A number of other equities research analysts have also commented on CME. UBS AG restated a “buy” rating and set a $134.00 price target (down from $136.00) on shares of CME Group in a research report on Monday, June 5th. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Friday. Royal Bank Of Canada set a $135.00 price target on CME Group and gave the stock a “buy” rating in a research report on Tuesday, August 1st. Jefferies Group LLC restated a “buy” rating and set a $128.00 price target on shares of CME Group in a research report on Monday, July 10th. Finally, Citigroup Inc. began coverage on CME Group in a research report on Wednesday, July 12th. They set a “buy” rating and a $140.00 price target on the stock. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company’s stock. CME Group has an average rating of “Buy” and an average price target of $131.63.
Shares of CME Group (CME) traded up 0.02% during mid-day trading on Friday, reaching $125.39. The company’s stock had a trading volume of 1,043,424 shares. The firm has a market capitalization of $42.62 billion, a P/E ratio of 25.60 and a beta of 0.73. The company has a 50 day moving average of $123.50 and a 200-day moving average of $121.13. CME Group has a 12 month low of $98.95 and a 12 month high of $127.96.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, topping the Zacks’ consensus estimate of $1.20 by $0.03. The business had revenue of $925 million for the quarter, compared to analyst estimates of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. CME Group’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the prior year, the company earned $1.14 EPS. Equities research analysts forecast that CME Group will post $4.80 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Keefe, Bruyette & Woods Reaffirms Hold Rating for CME Group Inc. (CME)” was originally published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://stocknewstimes.com/2017/08/18/keefe-bruyette-woods-reaffirms-hold-rating-for-cme-group-inc-cme.html.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction on Monday, July 10th. The stock was sold at an average price of $124.50, for a total value of $311,250.00. Following the transaction, the chief financial officer now owns 38,495 shares of the company’s stock, valued at approximately $4,792,627.50. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Kathleen M. Cronin sold 8,125 shares of the stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $127.35, for a total value of $1,034,718.75. Following the completion of the transaction, the insider now directly owns 38,174 shares in the company, valued at approximately $4,861,458.90. The disclosure for this sale can be found here. Insiders sold a total of 91,085 shares of company stock worth $11,242,896 over the last quarter. Corporate insiders own 0.61% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of CME. RMB Capital Management LLC increased its position in CME Group by 3.1% in the first quarter. RMB Capital Management LLC now owns 114,834 shares of the financial services provider’s stock worth $13,642,000 after buying an additional 3,501 shares during the period. Profund Advisors LLC increased its position in CME Group by 4.2% in the first quarter. Profund Advisors LLC now owns 11,222 shares of the financial services provider’s stock worth $1,333,000 after buying an additional 457 shares during the period. Thrivent Financial For Lutherans increased its position in CME Group by 5.6% in the first quarter. Thrivent Financial For Lutherans now owns 12,500 shares of the financial services provider’s stock worth $1,485,000 after buying an additional 660 shares during the period. Parsons Capital Management Inc. RI bought a new position in CME Group during the first quarter worth $569,000. Finally, Dowling & Yahnke LLC increased its position in CME Group by 1.7% in the first quarter. Dowling & Yahnke LLC now owns 6,844 shares of the financial services provider’s stock worth $813,000 after buying an additional 114 shares during the period. 83.25% of the stock is currently owned by institutional investors.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
